Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2691)
All Articles published online
|
Mar 7, 2008 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hakamada K, Kimura N, Miura T, Morohashi H, Ishido K, Nara M, Toyoki Y, Narumi S, Sasaki M. Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma. World J Gastroenterol 2008; 14(9): 1370-1377 [PMID: 18322950 DOI: 10.3748/wjg.14.1370] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i9/1370.htm |
| Number | Citing Articles |
| 1 |
Junichi Shindoh, Yasuhiko Sugawara, Rihito Nagata, Junichi Kaneko, Sumihito Tamura, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Tomohiro Tanaka, Norihiro Kokudo. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma. Transplant International 2014; 27(4): 391 doi: 10.1111/tri.12274
|
| 2 |
Fu-Jun Gao, Shu-Xiang Cui, Ming-Hui Chen, Yan-Na Cheng, Li-Rui Sun, S.G. Ward, Norihiro Kokudo, Wei Tang, Xian-Jun Qu. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sciences 2008; 83(23-24): 815 doi: 10.1016/j.lfs.2008.10.003
|
| 3 |
Dongjing Zhang, Zhihong Liu, Xueru Yin, Xiaolong Qi, Bingyun Lu, Yuanyuan Liu, Jinlin Hou. Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis. The International Journal of Biological Markers 2018; 33(3): 266 doi: 10.1177/1724600818760234
|
| 4 |
Carlo Saitta, Giuseppina Raffa, Angela Alibrandi, Santa Brancatelli, Daniele Lombardo, Gianluca Tripodi, Giovanni Raimondo, Teresa Pollicino. PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients. Medicine 2017; 96(26): e7266 doi: 10.1097/MD.0000000000007266
|
| 5 |
Masatsugu Ishii, Sho Ibuki, Jun Morinaga, Keita Shimata, Kazuya Hirukawa, Kaori Isono, Masaki Honda, Yasuhiko Sugawara, Yukihiro Inomata, Taizo Hibi. Elevated Alfa-Fetoprotein and Des-Gamma-Carboxy Prothrombin Levels Predict Poor Outcomes After Liver Transplantation for Hepatocellular Carcinoma Beyond the Japan Criteria. Transplantation Proceedings 2023; 55(3): 606 doi: 10.1016/j.transproceed.2023.02.047
|
| 6 |
Yang-Gun Suh, Eun-Jung Lee, Hyejung Cha, Seung-Hyun Yang, Jinsil Seong. Prognostic Values of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 in Hepatocellular Carcinoma after Radiotherapy. Digestive Diseases 2014; 32(6): 725 doi: 10.1159/000368010
|
| 7 |
Gaetano Bertino, Annalisa Ardiri, Michele Malaguarnera, Giulia Malaguarnera, Nicoletta Bertino, Giuseppe Stefano Calvagno. Hepatocellualar Carcinoma Serum Markers. Seminars in Oncology 2012; 39(4): 410 doi: 10.1053/j.seminoncol.2012.05.001
|
| 8 |
Ann Lövgren. Recombinant snake venom prothrombin activators. Bioengineered 2013; 4(3): 153 doi: 10.4161/bioe.22676
|
| 9 |
Yang Liu, Kazuyuki Sogawa, Masahiko Sunaga, Hiroshi Umemura, Mamoru Satoh, Takahiro Kazami, Masaharu Yoshikawa, Takeshi Tomonaga, Osamu Yokosuka, Fumio Nomura. Increased Concentrations of Apo A-I and Apo A-II Fragments in the Serum of Patients With Hepatocellular Carcinoma by Magnetic Beads–Assisted MALDI-TOF Mass Spectrometry. American Journal of Clinical Pathology 2014; 141(1): 52 doi: 10.1309/AJCPBLFBNAP6N2UN
|
| 10 |
Yoshinori Inagaki, Wei Tang, Masatoshi Makuuchi, Kiyoshi Hasegawa, Yasuhiko Sugawara, Norihiro Kokudo. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des‐γ‐carboxyprothrombin. Liver International 2011; 31(1): 22 doi: 10.1111/j.1478-3231.2010.02348.x
|
| 11 |
Murtadha M Jawad, Arshad N Aldujaili. Study of the effect of the phenolic extract of the Urtica dioica the level of Des-gamma-prothrombin after treatment with carbon tetrachloride. Journal of Physics: Conference Series 2019; 1294(6): 062031 doi: 10.1088/1742-6596/1294/6/062031
|
| 12 |
Subarna Thakur, Subhajit Ghosh. Transcriptome Profiling. 2023; : 453 doi: 10.1016/B978-0-323-91810-7.00007-8
|
| 13 |
Wei-Dong Kong, Jian-Ming Cao, Jian Xu, Bo Chen, Tao Yang, Tan-Tan Xu, Guang-Ming Lu, Jun Li, Xin-En Huang. Impact of Low Versus Conventional Doses of Chemotherapy During Transcatheter Arterial Chemo-embolization on Serum Fibrosis Indicators and Survival of Liver Cancer Patients. Asian Pacific Journal of Cancer Prevention 2012; 13(9): 4757 doi: 10.7314/APJCP.2012.13.9.4757
|
| 14 |
Anna Jonebring, Ute Lange, Elke Bucha, Johanna Deinum, Margareta Elg, Ann Lövgren. Expression and Characterization of Recombinant Ecarin. The Protein Journal 2012; 31(5): 353 doi: 10.1007/s10930-012-9409-6
|
| 15 |
Yasutsugu Takada, Taiji Tohyama, Jota Watanabe. Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(4): 279 doi: 10.1002/jhbp.195
|
| 16 |
Mohammed Elshamy, Federico Aucejo, K V Narayanan Menon, Bijan Eghtesad. Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria. World Journal of Hepatology 2016; 8(21): 874-880 doi: 10.4254/wjh.v8.i21.874
|
| 17 |
|
| 18 |
M. Fujiki, Y. Takada, Y. Ogura, F. Oike, T. Kaido, S. Teramukai, S. Uemoto. Significance of Des-Gamma-Carboxy Prothrombin in Selection Criteria for Living Donor Liver Transplantation for Hepatocellular Carcinoma. American Journal of Transplantation 2009; 9(10): 2362 doi: 10.1111/j.1600-6143.2009.02783.x
|
| 19 |
|
| 20 |
Soon Kyu Lee, Sung Won Lee, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(19): 10271 doi: 10.3390/ijms221910271
|
| 21 |
Chuanli Liu, Hongli Yang, Yuemin Feng, Cuihong Liu, Fajuan Rui, Yuankui Cao, Xinyu Hu, Jiawen Xu, Junqing Fan, Qiang Zhu, Jie Li. A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection. Journal of Clinical and Translational Hepatology 2022; 10(4): 600 doi: 10.14218/JCTH.2021.00348
|
| 22 |
Yong-Song Guan, Qing He, Ming-Quan Wang. Transcatheter Arterial Chemoembolization: History for More than 30 Years. ISRN Gastroenterology 2012; 2012: 1 doi: 10.5402/2012/480650
|
| 23 |
Satoru Takeji, Masashi Hirooka, Yohei Koizumi, Yoshio Tokumoto, Masanori Abe, Yoshio Ikeda, Seijin Nadano, Yoichi Hiasa, Morikazu Onji. Des‐gamma‐carboxy prothrombin identified by P‐11 and P‐16 antibodies reflects prognosis for patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2013; 28(4): 671 doi: 10.1111/jgh.12076
|
| 24 |
Katsunori Imai, Toru Beppu, Yoshiharu Nakayama, Takatoshi Ishiko, Kei Horino, Hiroyuki Komori, Toshiro Masuda, Hiromitsu Hayashi, Hirohisa Okabe, Yoshihumi Baba, Masayuki Watanabe, Hiroshi Takamori, Kazuo Awai, Yasuyuki Yamashita, Hideo Baba. Preoperative prediction of poorly differentiated components in small‐sized hepatocellular carcinoma for safe local ablation therapy. Journal of Surgical Oncology 2009; 100(2): 121 doi: 10.1002/jso.21302
|
| 25 |
Atsushi Nanashima, Syuuichi Tobinaga, Masaki Kunizaki, Satoshi Miuma, Naota Taura, Hiroaki Takeshita, Shigekazu Hidaka, Terumitsu Sawai, Kazuhiko Nakao, Takeshi Nagayasu. Strategy of treatment for hepatocellular Carcinomas with vascular infiltration in patients undergoing hepatectomy. Journal of Surgical Oncology 2010; 101(7): 557 doi: 10.1002/jso.21534
|
| 26 |
YASUNARI HIRAMINE, HIROFUMI UTO, YASUSHI IMAMURA, KAZUAKI TABU, YOSHIROU BABA, TAKUYA HIWAKI, YUKIHIKO SHO, KENJI TAHARA, HIROFUMI HIGASHI, TUTOMU TAMAI, MAKOTO OKETANI, AKIO IDO, HIROHITO TSUBOUCHI. Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study. Experimental and Therapeutic Medicine 2011; 2(3): 433 doi: 10.3892/etm.2011.237
|
| 27 |
Yanyan Wei, Feng Dai, Yongxiang Yi, Wei Ye, Wei Zhao. Impact of local tumor lesion treatments and preoperative indicators on the survival of patients with small hepatocellular carcinomas. Oncology Letters 2018; doi: 10.3892/ol.2018.9263
|